Skip to main content
. 2021 Feb 2;19:39. doi: 10.1186/s12955-021-01686-z

Table 2.

Participants’ European Quality of Life visual analogue scores by sociodemographic and clinical characteristics

Variable Frequency (%); N = 300 Median [Q1-Q3] P valuea
Age category (years)
Less than 60 182 (60.7) 70 [50–80] < 0.001b
60 or more 118 (39.3) 50 [29–70]
Gender
Male 166 (35.3) 60 [50–75] 0.429b
Female 134 (44.7) 66 [40–77]
Body mass index category
Underweight 12 (4.0) 70 [25–88] 0.003c
Healthy 96 (32.0) 70 [50–80]
Overweight 113 (37.7) 60 [40–80]
Obese 79 (26.3) 50 [35–70]
Residency
Refugee camp 30 (10.0) 75 [38–81] 0.141c
Village 175 (58.3) 63 [50–75]
City 95 (31.7) 60 [30–75]
Living arrangement
Alone 19 (6.3) 70 [50–75] 0.269b
With family 281 (93.7) 60 [40–75]
Educational level
No formal education 14 (4.7) 48 [18–71]  < 0.001c
Primary school 62 (20.7) 50 [30–70]
Secondary school 81 (27.0) 60 [40–77]
High school 67 (22.3) 60 [50–75]
Graduated 76 (25.3) 70 [55–84]
Social status
Married 220 (73.3) 60 [44–75] 0.729b
Single, divorced, or widowed 80 (26.7) 70 [31.2–80]
Employment
Unemployed 235 (78.3) 60 [40–70]  < 0.001b
Employed 65 (21.7) 75 [60–87]
Household monthly income
< 2000 NIS 178 (59.3) 60 [39–75] 0.001c
2000–4999 NIS 109 (36 .3) 65 [48–80]
> 5000 NIS 13 (4.3) 78 [70–85]
Dialysis vintage(years)
< 4 196 (65.3) 65 [41–78] 0.040b
≥ 4 104 (34.7) 58 [31–75]
Dialysis sessions per week
< 3 21 (7.0) 65 [53–73] 0.787c
3 276 (92.0) 60 [40–77]
≥ 4 3 (1.0) 75 [50-N/A]
Dialysis session duration (hours)
< 4 258 (86.0) 65 [40–77] 0.740b
≥ 4 42 (14.0) 60 [50–71]
Previous kidney transplantation
Yes 13 (4.3) 80 [40–78] 0.258b
No 287 (95.7) 60 [40–75]
Known cause for ESRD
Yes 281 (93.7) 65 [40–78] 0.439b
No 19 (6.3) 60 [40–70]
Chronic diseases category
None 30 (10.0) 75 [50–89] < 0.001c
1 77 (25.7) 70 [50–80]
2 86 (28.7) 65 [50–79]
≥ 3 107 (35.7) 50 [20–70]
Chronic medications category
< 4 10 (3.3) 50 [28–59] 0.037b
≥ 4 290 (96.7) 65 [40–77]
Smoking
Nonsmoker 218 (72.7) 65 [40–75] 0.439c
Light smoker 48 (16.0) 55 [50–80]
Smoker 34 (11.3) 68 [50–82]
Pain severity
Mild 219 (73.0) 70 [50–80] < 0.001c
Moderate 38 (12.7) 50 [35–61]
Severe 34 (14.3) 12 [10–40]
Pain interference
Low 241 (80.3) 70 [50–80] < 0.001b
High 59 (19.7) 20 [10–50]

ESRD, end stage renal disease; NIS, New Israeli shekel (1 NIS = 0.31 US Dollars)

aBold values denote statistical significance at the p < 0.05 level

bMann–Whitney U test

cKruskal–Wallis test